Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma. [electronic resource]
Producer: 20180417Description: 1441-1443 p. digitalISSN:- 1538-3598
No physical items for this record
Publication Type: Editorial; Comment
There are no comments on this title.
Log in to your account to post a comment.